SEVIA
Smartphone Enhanced Visual Inspection with Acetic Acid
Revolutionizing Cervical Cancer Screening in Tanzania
Transforming lives and simplifying daily tasks for millions.
Addressing Cervical Cancer Burden
Cervical cancer poses a silent threat to women in Tanzania, with a 63.7% incidence rate. Access to timely screening and expert opinions remains a challenge, contributing to delayed detection and treatment.
01
Challenge 01
63.7% of women diagnosed with cervical cancer in Tanzania die from the disease each year.
02
Challenge 02
18.8 million women aged 15-44 years of age, are at risk of developing cervical cancer.
03
Challenge 03
1st most frequent cancer among women in Tanzania affecting 10241 and more each year
SEVIA Project Overview
The Smartphone Enhanced Visual Inspection with Acetic Acid (SEVIA) represents a breakthrough in early cervical cancer detection. SEVIA enables real-time, secure transmission of cervical images. This empowers remote supervision, data monitoring, and evaluation – significantly improving the accuracy and efficiency of cervical cancer screenings.
This project has been conducted in phases
-
Phase One (July 2016 - June 2018) In collaboration with Queen’s University, Canada; New York University School of Global Public Health; Pamoja Tunaweza Women’s Centre Tanzania, USAID, and the Ministry of Health, Tanzania.
-
Phase Two (May 2022 - Present) In partnership with EGPAF Tanzania, and continuing collaborations with MOH and now our new partner ICAP.
SEVIA's Advanced Solutions
Explore SEVIA's advanced features and discover how we're transforming cervical cancer screening in Tanzania.
SEVIA Impact
in Tanzania
SEVIA is a cost-effective and transformative tool that revolutionizes cervical cancer care in Tanzania since 2016.
-
Enhanced Early Detection
-
Remote Diagnostic Support
-
Comprehensive Data Management
women screened for cervical cancer
HealthCare Providers trained to use SEVIA
VIA positive cases treated due to use of SEVIA
General SEVIA FAQs
Your questions answered
Discover more about SEVIA, our groundbreaking cervical cancer screening technology. This FAQ section provides answers to common questions about how SEVIA works, who can use it, and the support offered by SkyConnect.
No, SEVIA is available exclusively for partners who have entered into an agreement with SkyConnect and the Ministry of Health (MOH).
After entering into a contract, we provide the SEVIA app and web dashboard for data evaluations, regular updates and maintenance, training assistance, and training materials. Sevia app is both available for both Android and iOS platforms to ensure optimal usability and functionality.
Yes, SEVIA is designed to be particularly effective in remote areas. It facilitates remote supervision and support, ensuring that healthcare providers can offer quality diagnostic services even in locations with limited access to specialist care and internet.
SEVIA improves screening accuracy, increases access to expert review (especially in remote areas), streamlines the screening process, and enhances data tracking for better health monitoring.
SEVIA adheres to strict data privacy and security protocols to protect all patient information. The system ensures that data integrity and tracking are maintained at all times, complying with both local and international data protection regulations.
SEVIA utilizes advanced AI technology to enhance the accuracy and efficiency of cervical cancer screening. This includes real-time image sharing and analysis, which helps in early detection and accurate diagnosis.
Schedule Your SEVIA Demo Today
Ready to see how SEVIA can help in early detection of cervical cancer? Arrange a live demonstration and learn about the benefits and features of our system.
Join us to explore how SEVIA, our advanced cervical cancer screening technology, can enhance your healthcare services. We invites all institutions and hospitals to learn about integrating SEVIA to improve outcomes and patient care.
Prosper Ngalla
SEVIA Project Manager